Abstracts may be submitted for oral and poster presentations for the following topics:
1. PATHOGENESIS OF ATHEROSCLEROSIS |
1.1 Endothelial cell function and biology |
1.2 Smooth muscle cell biology |
1.3 Macrophages in lipid metabolism and atherosclerosis |
1.4 Inflammation, immunity and infection in atherosclerosis |
1.5 Extracellular matrix and calcification |
1.6 Vascular biology of the arterial wall: Miscellaneous |
1.7 Imaging technology |
1.8 Platelets, thrombosis and atherosclerosis |
1.9 Aortic valve stenosis |
1.10 Clonal Haematopoiesis |
1.11 Plaque remodelling |
1.12 Other |
2. LIPIDS AND LIPOPROTEINS |
2.1 Lp(a) |
2.2 TG rich lipoproteins metabolism and lipases |
2.3 HDL |
2.4 Lipoprotein receptors |
2.5 Bile acids |
2.6 Cholesterol efflux and reverse cholesterol transport |
2.7 Lipidomics |
2.8 Cellular lipid metabolism and lipid droplets |
2.9 Lipid and lipoprotein metabolism |
2.10 Modified lipoproteins |
2.11 Liver metabolism and steatosis |
2.12 Adipose tissue biology and pathology |
2.13 Other |
3. DYSLIPIDEMIA AND RISK FACTORS |
3.1 Epidemiology of cardiovascular diseases and risk factors |
3.2 Epidemiology of dyslipidemias |
3.3 Diabetes, insulin sensitivity and resistance |
3.4 Adipose tissue homeostasis |
3.5 Inherited dyslipidemias |
3.6 Gender and cardiovascular risk |
3.7 Environmental risk factors |
3.8 Novel risk factors and biomarkers |
3.9 Epidemiology of socioeconomic and psychosocial risk factors |
3.10 Coagulation |
3.11 Gut microbiome |
3.12 Gene editing technology |
3.13 Genomics, GWAS and population genetics; Mendelian randomization |
3.14 Epigenetics and microRNA |
3.15 Gene-Environment interactions |
3.16 Other |
4. CLINICAL VASCULAR DISEASE |
4.1 Coagulation and Thrombosis |
4.2 Endothelial dysfunction; Clinical assessment |
4.3 NASH and other ectopic lipid diseases |
4.4 Chronic kidney disease and nephropathies |
4.5 Diabetes; macro- and microangiopathies |
4.6 Aneurysms and other non-atherosclerotic arteriopathies |
4.7 Nutrition, nutraceuticals |
4.8 Bariatric surgery |
4.9 Lipid-lowering therapies |
4.10 Anti-thrombotic therapies |
4.11 Anti-inflammatory therapies |
4.12 Prevention and treatment of cardiovasculardisease; miscellaneous |
4.13 New lipid lowering therapies |
4.14 Other |